In humans, rare centenarian SIRT6 variants (N308K/A313S) exhibit enhanced interaction with Lamin A, increased mono-ADP-ribosyltransferase activity, stronger retrotransposon suppression, and improved cancer cell killing compared with wild-type SIRT6 [24]. This evidence concerns the gene SIRT6 and cancer.